Meeting
2024 ASCO Annual Meeting
Safety of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) in patients (pts) with biliary tract cancer with peritoneal metastases.
Authors
Daneng Li
City of Hope Comprehensive Cancer Center, Duarte, CA
Daneng Li , Christiana Crook , Vincent Chung , Gagandeep Brar , Marwan Fakih , Afsaneh Barzi , Laleh Golkar Melstrom , Gagandeep Singh , Yuman Fong , Paul Henry Frankel , Mustafa Raoof
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer - Advanced/Metastatic Disease
Clinical Trial Registration Number
NCT05285358
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr TPS4186)
DOI
10.1200/JCO.2024.42.16_suppl.TPS4186
Abstract #
TPS4186
Poster Bd #
163a
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer.
First Author: Mohamed Bouattour
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Varlitinib in combination with gemcitabine and cisplatin for treatment-naïve advanced biliary tract cancer.
First Author: Do-Youn Oh
Poster
2021 ASCO Annual Meeting
Association of cell-free DNA dominant clone allele frequency with poor outcomes in advanced biliary cancers treated with platinum-based chemotherapy.
First Author: Umair Majeed
Poster
2019 Gastrointestinal Cancers Symposium
A multicenter, phase Ib/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment of naïve, advanced, or metastatic biliary tract cancer (BTC).
First Author: Do-Youn Oh